April 2023 Global Innovation Drug Report

This April 2023 Global Innovative Drug Report, based on data from the PatSnap Synapse database, offers a comprehensive overview of the latest advancements in the pharmaceutical industry. Divided into four parts, it examines the R&D status, active patents, mechanisms of action, clinical trials, competitive landscape, and other pertinent factors of each selected drug.

1. The first approved drugs in April 

2. Comprehensive analysis of newly introduced medications

3. Global drugs under Expedited Review Pathway in April 

4. In-depth analysis of selected ERP drugs 

Download the report HERE